Safety of a New Oral Contraceptive Containing Drospirenone

ISSN： 0114-5916

Source： Drug Safety, Vol.27, Iss.13, 2004-01, pp. : 1001-1018

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy and Safety of a Low-Dose 21-Day Combined Oral Contraceptive Containing Ethinylestradiol 20µg and Drospirenone 3mg

By Cibula D.

Clinical Drug Investigation, Vol. 26, Iss. 3, 2006-01 ,pp. : 143-150

Adis International

Access to resources Recommend Favorite

Bioequivalence Evaluation of a Folate-Supplemented Oral Contraceptive Containing Ethinylestradiol/Drospirenone/Levomefolate Calcium versus Ethinylestradiol/Drospirenone and Levomefolate Calcium Alone

By Wiesinger Herbert

Clinical Drug Investigation, Vol. 32, Iss. 10, 2012-10 ,pp. : 673-684

Adis International

Access to resources Recommend Favorite

Added Benefits and User Satisfaction with a Low-Dose Oral Contraceptive Containing Drospirenone: Results of Three Multicentre Trials

By Bitzer Johannes

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 73-78

Adis International

Access to resources Recommend Favorite

The combined oral contraceptive pill containing drospirenone and ethinyl estradiol plus levomefolate calcium

By Rapkin Rachel B Creinin Mitchell D

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 15, 2011-10 ,pp. : 2403-2410

Informa Healthcare

Access to resources Recommend Favorite

Low-dose ethinylestradiol/drospirenone effective oral contraceptive

Inpharma, Vol. 1, Iss. 1535, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite